Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F9EGU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,093
Award facts
- Contract value 100% obligated
- $32,092.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $32,092.59 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on February 3, 2026, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pump pods. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This is a non-set-aside competitive award, reflecting Amerisourcebergen's capability to meet federal procurement requirements through open competition. The contract is a delivery order executed under a larger vehicle structure, consistent with DLA's medical supply chain operations that support military healthcare systems and veteran services.
Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor and healthcare solutions provider. The parent company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the comprehensive global pharmaceutical support vehicle enabling delivery of a wide range of pharmaceutical products and medical supplies to military treatment facilities worldwide. This specific delivery order for insulin pump pods exemplifies the company's role in supplying specialized diabetes management devices to support federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9EGU?
SPE2DR26F9EGU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F9EGU worth?
The government has obligated $32,093 on SPE2DR26F9EGU.
Is contract SPE2DR26F9EGU an order under another contract?
Yes. SPE2DR26F9EGU is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EGU competed?
The extent of competition for SPE2DR26F9EGU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award